viewAusCann Group Holdings Ltd
The online education resources aim to bring awareness to medical professionals.
() has released a series of online courses for Australian health professionals, as a part of its Medical Outreach Program.
The online education courses aim to support Australian health professionals make informed decisions regarding cannabinoid therapeutics.
AusCann’s chairman Dr Mal Washer said: “It is essential that Australian doctors are informed about the endocannabinoid system and cannabinoid therapeutics so that they can make informed decisions regarding treatment possibilities.
“Until it becomes part of the medical syllabus, there is a need to provide accessible, referenced, objective information about cannabinoid medicines that doctors and other health professionals can draw upon to inform their thinking.”
READ: AusCann Group signs a medical cannabis deal with Columbia based Khiron Life Sciences
AusCann’s chief medical advisor Dr Danial Schecter built an experienced team for the outreach program.
The online courses represent the latest component of that outreach program.
READ: AusCann Group commences trading in the US increasing global exposure
AusCann recently commenced trading on the US OTCQX Market under the stock symbol ACNNF.
Trading on the OTCQX supports AusCann’s strategy to broaden its international investor base, particularly in North America where it has a number of strategic agreements in place.
ASX:AC8
Market: ASX
Market Cap: $93.53 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of AusCann Group Holdings Ltd named herein, including the promotion by the Company of AusCann Group Holdings Ltd in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Auscann targeting pain management with Australian cannabinoid products
Elaine Darby, managing director of Auscann Group Holdings Ltd (ASX:AC8), spoke to Proactive Investors at the ASX Small and Mid-Cap Conference in Sydney. Auscann is continuing to make steady progress towards releasing its first medicinal cannabis products during the financial year 2019....
on 09/05/2018
2 min read
Prev article
2 min read
